Literature DB >> 7242273

Diet and high density lipoproteins.

P Oster, G Schlierf, C C Heuck, S Hahn, H Szymanski, B Schellenberg.   

Abstract

The acute and subacute effects of different diets on serum high density lipoprotein (HDL) cholesterol concentration and/or HDL composition are described. In obese normolipemic, hypercholesterolemic (type II) and hypertriglyceridemic (type IV) patients, low HDL cholesterol values remained low during total starvation for 2 weeks. Prudent diets in patients with type II and IV hyperlipoproteinemia had no significant effects on HDL cholesterol within 3 weeks, whereas in normal individuals, a high carbohydrate diet given for 10 days caused significant decreases in HDL cholesterol with concomitant increases in HDL triglycerides as compared to a high-fat diet. The HDL triglyceride fatty acid composition changed in healthy volunteers during the day, depending on the type of ingested fat. The data demonstrate the possibility of acute manipulations of HDL in normal patients and the difficulties of normalizing low HDL cholesterol levels in patients by dietary means. Additional information on the function of HDL is desirable before the therapeutic manipulation of HDL cholesterol or other constituents of HDL can be evaluated regarding their effectiveness in the prevention of ischemic vascular disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7242273     DOI: 10.1007/bf02535680

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  33 in total

1.  Acute dietary effects on plasma lipids, lipoproteins and lipolytic enzymes in healthy normal males.

Authors:  G Schlierf; S Jessel; J Ohm; C C Heuck; G Klose; P Oster; B Schellenberg; A Weizel
Journal:  Eur J Clin Invest       Date:  1979-10       Impact factor: 4.686

2.  Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol.

Authors:  J M Falko; J L Witztum; G Schonfeld; J Bateman
Journal:  Ann Intern Med       Date:  1979-11       Impact factor: 25.391

3.  The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis.

Authors:  D Steinberg
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

4.  Metabolic regulation of plasma high density lipoprotein concentrations.

Authors:  E A Nikkila
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

5.  The transport of triglyceride in the high-density lipoproteins of human plasma.

Authors:  P J Barter; W E Connor
Journal:  J Lab Clin Med       Date:  1975-02

6.  Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention.

Authors:  S B Hulley; R Cohen; G Widdowson
Journal:  JAMA       Date:  1977-11-21       Impact factor: 56.272

7.  Relation of plasma high-density lipoprotein cholesterol to lipoprotein-lipase activity in adipose tissue and skeletal muscle of man.

Authors:  E A Nikkilä; M R Taskinen; M Kekki
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

8.  Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford three-community study.

Authors:  M P Stern; B W Brown; W L Haskell; J W Farquhar; C L Wehrle; P D Wood
Journal:  JAMA       Date:  1976-02-23       Impact factor: 56.272

9.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

Authors:  J J Albers; P W Wahl; V G Cabana; W R Hazzard; J J Hoover
Journal:  Metabolism       Date:  1976-06       Impact factor: 8.694

10.  Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol.

Authors:  R W Mahley; T L Innerarity; T P Bersot; A Lipson; S Margolis
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

View more
  1 in total

1.  Treatment of coronary heart disease by diet and exercise: fasting and diurnal lipoproteins.

Authors:  G Schlierf; G Schuler; A Wirth; M Kohlmeier; G Vogel
Journal:  Klin Wochenschr       Date:  1988-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.